23 Results

People

  1. Yu
    Yu
  2. Chou
    Chou
  3. Dong
    Dong
  4. Falcon
    Falcon
  5. Kris
    Kris
  6. Ladanyi
    Ladanyi
  7. Paik
    Paik
  8. Rudin
    Rudin
  9. Zhang
    Zhang
  10. Ahn
    Ahn

Groups

  1. Department of Medicine (13)
  2. Solid Tumor Oncology Division (8)
  3. Thoracic Oncology (7)
  4. Center for Hematologic Malignancies (5)
  5. Hematologic Malignancies, Division of (5)
  6. GSK Faculty (4)
  7. Adult Leukemia (3)
  8. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (3)
  9. GME, Medicine (3)
  10. Graduate Medical Education (3)
  1. "aniline derivative"
Formats
  1. Journal Article (21)
  2. Correspondence (1)
  3. Research Letter (1)
Groups
  1. Department of Medicine (13)
  2. Solid Tumor Oncology Division (8)
  3. Thoracic Oncology (7)
  4. Center for Hematologic Malignancies (5)
  5. Hematologic Malignancies, Division of (5)
  6. GSK Faculty (4)

More Groups

People
  1. Ting-Chao Chou (7)
  2. Helena Yu (6)
  3. Charles Rudin (2)
  4. Christina Falcon (2)
  5. Emily Miao (2)
  6. Huajin Dong (2)

More People

Years
  1. 2025 (1)
  2. 2024 (4)
  3. 2023 (4)
  4. 2022 (5)
  5. 2019 (1)
  6. 2008 (1)

More Years

Publications
  1. Clinical Cancer Research (5)
  2. Bioorganic & Medicinal Chemistry (3)
  3. Journal of Clinical Oncology (3)
  4. Cancer Discovery (2)
  5. Journal of Medicinal Chemistry (2)
  6. Annals of Oncology (1)

More Publications

Publishers
  1. American Association for Cancer Research (7)
  2. Pergamon-Elsevier Science Ltd (4)
  3. American Society of Clinical Oncology (3)
  4. American Chemical Society (2)
  5. Academic Press Inc., Elsevier Science (1)
  6. Biomed Central Ltd (1)

More Publishers

Results (23)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Real-world analysis of the safety/tolerability of gilteritinib in combination with mold-active azole prophylaxis
    Research Letter

    King, A. C.; Derkach, A.; Weis, T. M.; Stump, S. E.; Ciervo, J. R.; Ranaghan, C. P.; Stein, E. S.
    Leukemia Research (2022)

    Fulltext@MSK | Save
  • Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia: Final results from the BFORE trial
    Journal Article

    Brümmendorf, T. H.; Cortes, J. E.; Milojkovic, D.; Gambacorti-Passerini, C.; Clark, R. E.; le Coutre, P.; Garcia-Gutierrez, V.; Chuah, C.; Kota, V.; Lipton, J. H.; more...
    Leukemia (2022)

    Fulltext@MSK | Save
  • A phase I study investigating AZD8186, a potent and selective inhibitor of PI3Kβ/δ, in patients with advanced solid tumors
    Journal Article

    Choudhury, A. D.; Higano, C. S.; de Bono, J. S.; Cook, N.; Rathkopf, D. E.; Wisinski, K. B.; Martin-Liberal, J.; Linch, M.; Heath, E. I.; Baird, R. D.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Targeting S100A9–ALDH1A1–retinoic acid signaling to suppress brain relapse in EGFR-mutant lung cancer
    Journal Article

    Biswas, A. K.; Han, S.; Tai, Y.; Ma, W.; Coker, C.; Quinn, S. A.; Shakri, A. R.; Zhong, T. J.; Scholze, H.; Lagos, G. G.; more...
    Cancer Discovery (2022)

    Fulltext@MSK | Save
  • Gilteritinib or chemotherapy for relapsed or refractory FLT3-mutated AML
    Journal Article

    Perl, A. E.; Martinelli, G.; Cortes, J. E.; Neubauer, A.; Berman, E.; Paolini, S.; Montesinos, P.; Baer, M. R.; Larson, R. A.; Ustun, C.; more...
    New England Journal of Medicine (2019)

    Fulltext@MSK | Save
  • Synthesis and biological activity of stable and potent antitumor agents, aniline nitrogen mustards linked to 9-anilinoacridines via a urea linkage
    Journal Article

    Kapuriya, N.; Kapuriya, K.; Zhang, X.; Chou, T. C.; Kakadiya, R.; Wu, Y. T.; Tsai, T. H.; Chen, Y. T.; Lee, T. C.; Shah, A.; more...
    Bioorganic & Medicinal Chemistry (2008)

    Fulltext@MSK | Save
  • Potent antitumor 9-anilinoacridines and acridines bearing an alkylating N-mustard residue on the acridine chromophore: Synthesis and biological activity
    Journal Article

    Su, T. L.; Lin, Y. W.; Chou, T. C.; Zhang, X.; Bacherikov, V. A.; Chen, C. H.; Liu, L. F.; Tsai, T. J.
    Journal of Medicinal Chemistry (2006)

    Fulltext@MSK | Save
  • Synthesis and antitumor activity of 5-(9-acridinylamino)anisidine derivatives
    Journal Article

    Bacherikov, V. A.; Chang, J. Y.; Lin, Y. W.; Chen, C. H.; Pan, W. Y.; Dong, H.; Lee, R. Z.; Chou, T. C.; Su, T. L.
    Bioorganic & Medicinal Chemistry (2005)

    Fulltext@MSK | Save
  • Potent antitumor N-mustard derivatives of 9-anilinoacridine, synthesis and antitumor evaluation
    Journal Article

    Bacherikov, V. A.; Chou, T. C.; Dong, H. J.; Chen, C. H.; Lin, Y. W.; Tsai, T. J.; Su, T. L.
    Bioorganic & Medicinal Chemistry Letters (2004)

    Fulltext@MSK | Save
  • Non-classical antifolates, 5-(N-phenylpyrrolidin-3-yl)-2,4,6-triaminopyrimidines and 2,4-Diamino-6(5H)-oxopyrimidines, synthesis and antitumor studies
    Journal Article

    Huang, Y. L.; Lin, C. F.; Lee, Y. J.; Li, W. W.; Chou, T. C.; Bacherikov, V. A.; Chen, K. T.; Chen, C. M.; Su, T. L.
    Bioorganic & Medicinal Chemistry (2003)

    Fulltext@MSK | Save